| Dr Matias Elijovich, MD | |
|
1000 E Mountain Blvd, Wilkes Barre, PA 18711-0027 | |
| (570) 808-7762 | |
| (570) 808-6128 |
| Full Name | Dr Matias Elijovich |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 1000 E Mountain Blvd, Wilkes Barre, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376761163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD436692 (Pennsylvania) | Primary |
| 207P00000X | Emergency Medicine | MT188780 (Pennsylvania) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger St. Luke's Hospital | Orwigsburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gslpg, Inc | 7810226875 | 227 |
News Archive
UL, a world leader in advancing safety, offers critical safety information for post-hurricane Sandy recovery
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the winner of the first Netter Atlas Medical Illustration Contest.
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
E-cigarette use significantly increases a person's risk of developing chronic lung diseases like asthma, bronchitis, emphysema or chronic obstructive pulmonary disease, according to new UC San Francisco research, the first longitudinal study linking e-cigarettes to respiratory illness in a sample representative of the entire U.S. adult population.
Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
› Verified 7 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
UL, a world leader in advancing safety, offers critical safety information for post-hurricane Sandy recovery
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the winner of the first Netter Atlas Medical Illustration Contest.
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
E-cigarette use significantly increases a person's risk of developing chronic lung diseases like asthma, bronchitis, emphysema or chronic obstructive pulmonary disease, according to new UC San Francisco research, the first longitudinal study linking e-cigarettes to respiratory illness in a sample representative of the entire U.S. adult population.
Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
› Verified 7 days ago
| Entity Name | Emergency Physician Associates Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619990900 PECOS PAC ID: 5597663252 Enrollment ID: O20040913000755 |
News Archive
UL, a world leader in advancing safety, offers critical safety information for post-hurricane Sandy recovery
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the winner of the first Netter Atlas Medical Illustration Contest.
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
E-cigarette use significantly increases a person's risk of developing chronic lung diseases like asthma, bronchitis, emphysema or chronic obstructive pulmonary disease, according to new UC San Francisco research, the first longitudinal study linking e-cigarettes to respiratory illness in a sample representative of the entire U.S. adult population.
Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
› Verified 7 days ago
| Entity Name | Emergency Care Services Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114955010 PECOS PAC ID: 1759301799 Enrollment ID: O20051206000046 |
News Archive
UL, a world leader in advancing safety, offers critical safety information for post-hurricane Sandy recovery
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the winner of the first Netter Atlas Medical Illustration Contest.
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
E-cigarette use significantly increases a person's risk of developing chronic lung diseases like asthma, bronchitis, emphysema or chronic obstructive pulmonary disease, according to new UC San Francisco research, the first longitudinal study linking e-cigarettes to respiratory illness in a sample representative of the entire U.S. adult population.
Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
› Verified 7 days ago
| Entity Name | Gslpg, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366006702 PECOS PAC ID: 7810226875 Enrollment ID: O20190917001763 |
News Archive
UL, a world leader in advancing safety, offers critical safety information for post-hurricane Sandy recovery
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the winner of the first Netter Atlas Medical Illustration Contest.
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
E-cigarette use significantly increases a person's risk of developing chronic lung diseases like asthma, bronchitis, emphysema or chronic obstructive pulmonary disease, according to new UC San Francisco research, the first longitudinal study linking e-cigarettes to respiratory illness in a sample representative of the entire U.S. adult population.
Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matias Elijovich, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dr Matias Elijovich, MD 1000 E Mountain Blvd, Wilkes Barre, PA 18711-0027 Ph: (570) 808-7762 |
News Archive
UL, a world leader in advancing safety, offers critical safety information for post-hurricane Sandy recovery
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the winner of the first Netter Atlas Medical Illustration Contest.
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
E-cigarette use significantly increases a person's risk of developing chronic lung diseases like asthma, bronchitis, emphysema or chronic obstructive pulmonary disease, according to new UC San Francisco research, the first longitudinal study linking e-cigarettes to respiratory illness in a sample representative of the entire U.S. adult population.
Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).
› Verified 7 days ago
Dr. Anthony Ascione, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 575 N River St, Wilkes Barre, PA 18764 Phone: 570-829-8111 | |
Gary Bonfante, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7762 Fax: 570-808-6128 | |
Dr. Lino A. Quilo, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 25 Church St, Wilkes Barre, PA 18765 Phone: 570-826-3100 | |
Todd C Daniello, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7762 | |
Dr. Patricia M. Ihnat-shroff, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 575 North River Street, Wilkes Barre, PA 18765 Phone: 570-826-3100 | |
Dr. Jeffrey Brian Adler, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 E Mountain Dr, Wilkes Barre, PA 18711 Phone: 570-808-7762 Fax: 570-808-6128 | |
Dan Alan Loughran, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Dr, Wilkes Barre, PA 18711 Phone: 570-808-7762 |